Somerset Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,524
| Closed | -$253K | – | 62 |
|
|
2025
Q1 | $253K | Sell |
1,524
-510
| -25% | -$79.8K | 0.23% | 60 |
|
|
2024
Q4 | $294K | Hold |
2,034
| – | – | 0.27% | 53 |
|
|
2024
Q3 | $330K | Hold |
2,034
| – | – | 0.3% | 52 |
|
|
2024
Q2 | $297K | Hold |
2,034
| – | – | 0.26% | 54 |
|
|
2024
Q1 | $322K | Sell |
2,034
-116
| -5% | -$18.5K | 0.3% | 47 |
|
|
2023
Q4 | $337K | Hold |
2,150
| – | – | 0.28% | 51 |
|
|
2023
Q3 | $335K | Sell |
2,150
-1,034
| -32% | -$171K | 0.32% | 51 |
|
|
2023
Q2 | $527K | Hold |
3,184
| – | – | 0.44% | 45 |
|
|
2023
Q1 | $494K | Hold |
3,184
| – | – | 0.43% | 43 |
|
|
2022
Q4 | $562K | Hold |
3,184
| – | – | 0.5% | 41 |
|
|
2022
Q3 | $520K | Hold |
3,184
| – | – | 0.48% | 41 |
|
|
2022
Q2 | $565K | Hold |
3,184
| – | – | 0.49% | 40 |
|
|
2022
Q1 | $564K | Hold |
3,184
| – | – | 0.4% | 44 |
|
|
2021
Q4 | $545K | Sell |
3,184
-194
| -6% | -$31.8K | 0.37% | 48 |
|
|
2021
Q3 | $546K | Hold |
3,378
| – | – | 0.39% | 47 |
|
|
2021
Q2 | $556K | Sell |
3,378
-35
| -1% | -$5.79K | 0.4% | 46 |
|
|
2021
Q1 | $561K | Buy |
3,413
+1,134
| +50% | +$183K | 0.42% | 46 |
|
|
2020
Q4 | $359K | Sell |
2,279
-101
| -4% | -$14.9K | 0.29% | 51 |
|
|
2020
Q3 | $354K | Hold |
2,380
| – | – | 0.32% | 50 |
|
|
2020
Q2 | $335K | Hold |
2,380
| – | – | 0.33% | 48 |
|
|
2020
Q1 | $312K | Hold |
2,380
| – | – | 0.36% | 46 |
|
|
2019
Q4 | $347K | Hold |
2,380
| – | – | 0.3% | 50 |
|
|
2019
Q3 | $308K | Hold |
2,380
| – | – | 0.26% | 59 |
|
|
2019
Q2 | $331K | Hold |
2,380
| – | – | 0.28% | 53 |
|
|
2019
Q1 | $333K | Hold |
2,380
| – | – | 0.28% | 52 |
|
|
2018
Q4 | $307K | Hold |
2,380
| – | – | 0.31% | 50 |
|
|
2018
Q3 | $329K | Hold |
2,380
| – | – | 0.26% | 55 |
|
|
2018
Q2 | $289K | Hold |
2,380
| – | – | 0.25% | 56 |
|
|
2018
Q1 | $305K | Sell |
2,380
-100
| -4% | -$13.5K | 0.27% | 55 |
|
|
2017
Q4 | $347K | Hold |
2,480
| – | – | 0.29% | 59 |
|
|
2017
Q3 | $322K | Hold |
2,480
| – | – | 0.29% | 55 |
|
|
2017
Q2 | $328K | Hold |
2,480
| – | – | 0.3% | 57 |
|
|
2017
Q1 | $309K | Sell |
2,480
-50
| -2% | -$5.97K | 0.29% | 57 |
|
|
2016
Q4 | $291K | Sell |
2,530
-226
| -8% | -$26.1K | 0.29% | 56 |
|
|
2016
Q3 | $326K | Buy |
2,756
+100
| +4% | +$12.1K | 0.33% | 56 |
|
|
2016
Q2 | $322K | Hold |
2,656
| – | – | 0.34% | 56 |
|
|
2016
Q1 | $287K | Hold |
2,656
| – | – | 0.31% | 58 |
|
|
2015
Q4 | $273K | Sell |
2,656
-254
| -9% | -$25.5K | 0.29% | 64 |
|
|
2015
Q3 | $272K | Hold |
2,910
| – | – | 0.3% | 61 |
|
|
2015
Q2 | $284K | Sell |
2,910
-54
| -2% | -$5.41K | 0.27% | 62 |
|
|
2015
Q1 | $298K | Hold |
2,964
| – | – | 0.27% | 64 |
|
|
2014
Q4 | $310K | Hold |
2,964
| – | – | 0.28% | 64 |
|
|
2014
Q3 | $316K | Hold |
2,964
| – | – | 0.29% | 63 |
|
|
2014
Q2 | $310K | Sell |
2,964
-15
| -0.5% | -$1.52K | 0.28% | 63 |
|
|
2014
Q1 | $293K | Sell |
2,979
-10
| -0.3% | -$927 | 0.28% | 64 |
|
|
2013
Q4 | $274K | Sell |
2,989
-50
| -2% | -$4.61K | 0.21% | 68 |
|
|
2013
Q3 | $263K | Hold |
3,039
| – | – | 0.19% | 68 |
|
|
2013
Q2 | $261K | Buy |
+3,039
| New | +$258K | 0.19% | 69 |
|
Other funds holding JNJ
Somerset Group's JNJ Position: Q2 2025 in Review
Somerset Group sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 1,524 shares — an estimated $253K sold.
Somerset Group first reported a position in JNJ in Q2 2013 and held it in 48 quarters. The position peaked at $565K in Q2 2022. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.
- Somerset Group reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
- Somerset Group sold 1,524 Johnson & Johnson shares in Q2 2025, an estimated $253K.
- Somerset Group first reported a position in Johnson & Johnson in Q2 2013 and held it in 48 quarters.
- Somerset Group's Johnson & Johnson position peaked at $565K in Q2 2022.
- 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.
Based on Somerset Group's 13F filing for Q2 2025, filed 11 Aug 2025.